Tag: Novartis Oncology
Up-to-the-Minute: News for the Carcinoid and Neuroendocrine Tumor Community
The first device that simultaneously performs PET and MRI scans, a new alpha-emitter-based therapy for NET cancer patients with progressive therapy-resistant tumors, the first–ever randomized virtual clinical trial, over 100 abstracts on carcinoid…
READ MOREBreaking News: FDA Approves Treatment for pNET Patients
For the first time in nearly three decades, there is a new treatment for pancreatic neuroendocrine tumor patients! The Food and Drug Administration (FDA) today announced its approval of Afinitor© for pNET patients. This is a milestone for the carcinoid/NET…
READ MORECarcinoid Cancer Foundation Thanks Symposium Sponsors
There’s still time to register for the Carcinoid Cancer Foundation’s 14th annual symposium for patients, family, friends, and healthcare professionals, which will be held on Sunday, May 1st at Mount Sinai Medical Center in New York City. The Foundation…
READ MORECNETS Canada Presents 2011 Halifax Neuroendocrine Conference for Patients and Medical Professionals
Carcinoid and neuroendocrine tumor patients and medical professionals are invited to attend the 2011 Halifax Conference, presented by the Canadian Neuroendocrine Tumour Society (CNETS). The conference will be held on Saturday, May 7 at the beautiful…
READ MORENovartis Oncology Announces Winner of 2010 Warner Advocacy Award
Maryann Wahmann of the Carcinoid Cancer Awareness Network (CCAN) has been chosen as winner of the 2010 Warner Advocacy Award, established last year by Novartis Oncology to commemorate the life and work of the late Monica Warner of the Carcinoid Cancer…
READ MORE12 iPhone Apps for Patients and Physicians
For carcinoid and neuroendocrine cancer iPhone users there are many resources for you as a patient or for your physician that have been created by big pharmaceutical companies around the world. These pharma companies include Novartis, Pfizer, Merck…
READ MOREAdvocacy Award Honors the Late Monica Warner of the Carcinoid Cancer Foundation: Call for Nominations
Novartis Oncology has announced its 2010 Warner Advocacy Award named in honor of Monica Warner, a driving force behind the Carcinoid Cancer Foundation for two decades and an extraordinary advocate for carcinoid and neuroendocrine tumor patients. …
READ MORESandostatin Mobile Administration Program for Carcinoid Syndrome Patients
If you are a carcinoid patient who needs Sandostatin® LAR Depot injections, you may be eligible for the Mobile Administration Program. This program helps alleviate the stress of driving to a doctor’s office (or finding one where you live or while on vacation),…
READ MOREVideo Recording of National Carcinoid Cancer and Neuroendocrine Tumor Patient Conference Now Online
Whether you are newly diagnosed with carcinoid cancer or another neuroendocrine tumor or you are seeking novel treatments for NETs you can gain invaluable information from the video recording of the 2009 National Carcinoid/NET Patient Conference …
READ MORE